Which is customized for every patient, so it currently costs $500,000 and isn’t FDA approved for wide use, AND it is only available inside the US in a limited number of facilities.
Still, it’s very promising, and if it holds up, it’ll eventually be more widespread. At the end of the article it says they’re working on a more generalized approach that could lower the cost and increase availability.
“a repurposed cancer treatment called CAR-T-cell therapy”
Which is customized for every patient, so it currently costs $500,000 and isn’t FDA approved for wide use, AND it is only available inside the US in a limited number of facilities.
Still, it’s very promising, and if it holds up, it’ll eventually be more widespread. At the end of the article it says they’re working on a more generalized approach that could lower the cost and increase availability.